Qvents

Qvents

Discussion forum for Pharma Quality events, Regulatory Actions

Qvents Qvents
  • Home 
    • About Us 
    • Contact Us 
    • Expert Panel 
    • Tags 
  • Qvents 
    • Warning Letters 
    • 483s 
    • Recalls 
    • Import Alerts 
    • Quality Insights 
    • Tags 
  • Forums 
  • Learning Resources 
    • Upcoming Trainings 
    • Training Archives 
  • Guidelines 
  • Pharma Jobs 
    • Job Openings 
    • Post a Job
      • Jobs posted by me 
  • Users & Profiles 
  • News 
  • Login/Register
    • Individual
    • Company
Qvents Qvents
Qvents
  • Home 
    • About Us 
    • Contact Us 
    • Expert Panel 
    • Tags 
  • Qvents 
    • Warning Letters 
    • 483s 
    • Recalls 
    • Import Alerts 
    • Quality Insights 
    • Tags 
  • Forums 
  • Learning Resources 
    • Upcoming Trainings 
    • Training Archives 
  • Guidelines 
  • Pharma Jobs 
    • Job Openings 
    • Post a Job
      • Jobs posted by me 
  • Users & Profiles 
  • News 
  • Login/Register
shape
shape
shape
shape

Tag: Drug Alerts

CDSCO’s NSQ Alerts – May 2025: Centr

Indian drug regulator CDSCO has published the Not of Standard Quality (NSQ) alert lists for

Qvents
June 25, 2025

CDSCO Publishes NSQ Drugs List for March

Indian drug regulator CDSCO (Central Drugs Standards Control Organisation) has published the Not of Standard

Qvents
May 2, 2025

CDSCO Not of Standard Quality Drug Alert

The Central Drugs Standard Control Organisation (CDSCO) has published the NSQ (Not of Standard Quality)

Qvents
April 9, 2025

CDSCO Drug Alert: Assay, Dissolution Fai

In December 2024, the Indian drug regulator, CDSCO, flagged 51 drugs as Not of Standard

Qvents
January 27, 2025

CDSCO Flags Spurious and Poor Quality Dr

The Indian drug regulator, CDSCO, has published a list of spurious drugs detected in November

Qvents
December 31, 2024

CDSCO Issues Spurious Drug Alert for Pop

The Central Drugs Standard Control Organization (CDSCO) has issued a spurious drug alert for popular

Qvents
December 3, 2024

EC General Court Refuses to Extend Suspe

In September 2024, the European Commission (EC) revoked the Conditional Marketing Authorisation (CMA) for Advanz

Qvents
November 28, 2024

Oral Phenylephrine Not Effective: FDA Pr

USFDA is proposing to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) drug

Qvents
November 11, 2024

CDSCO Quality Alert for 67 Medicines in

CDSCO has published list of sixtyseven Drugs & Medicinal products as Not of Standard Quality

Qvents
October 25, 2024

CDSCO Flags Spurious Drugs of PAN D, Uri

CDSCO has published list of drugs declared as spurious in the month of September 2024.

Qvents
October 24, 2024

1 2
  • Facebook
  • LinkedIn
  • Twitter

Search Posts

Latest Posts

Loss of Potency: Accord / Intas Recall Hypothyroidism / Thyroxine Drug
July 25, 2025
Nitrosamine Impurities in Pharmaceutical Products: Templates for Risk Assessment and Supplier Evaluation
June 28, 2025
Supply Chain Traceability of Medicinal Products
May 31, 2025
Continuous Process Verification (CPV) and Evaluation Templates
May 16, 2025
Concerns of Beta-lactam Contamination Triggers Massive Recall by Glenmark
April 28, 2025
footer shape 1
footer shape 2
 Quick Links 
  • Forums
  • Warning Letters
  • 483s
  • Recalls
  • Import Alerts
  • Quality Insights
 
  • News
  • Guidelines
  • Pharma Jobs
  • Job Openings
  • Post a Job
 
  • Users & Profiles
  • Trainings and Webinar
  • About Us
  • Contact Us
  • Facebook
  • LinkedIn
  • Twitter

© 2023 All Rights Reserved by Qvents

  • Terms and Conditions
  • Privacy Policy